博信股份(600083.SH)控股股東6530.01萬股輪候凍結
格隆匯11月18日丨博信股份(600083.SH)公佈,公司經瞭解獲悉,公司控股股東蘇州晟雋所持有公司6530.0094萬股(無限售流通股)被上海金融法院予以輪候凍結,凍結期限為三年,自正式凍結之日起算。蘇州晟雋持有的公司股份全部被輪候凍結,佔公司總股本的28.3913%。
經瞭解,諾亞(上海)融資租賃有限公司對廣東承興控股集團有限公司、蘇州晟雋營銷管理有限公司、羅靜等就其他合同糾紛事項向上海金融法院提起訴訟,並申請財產保全。因財產保全需要,上海金融法院依法輪候凍結蘇州晟雋持有的公司6530.0094萬股股份。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.